301 related articles for article (PubMed ID: 14623936)
1. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA.
Muskhelishvili L; Latendresse JR; Kodell RL; Henderson EB
J Histochem Cytochem; 2003 Dec; 51(12):1681-8. PubMed ID: 14623936
[TBL] [Abstract][Full Text] [Related]
2. In situ localization of S-phase-specific histone (H3) mRNA in Bowen's disease.
Murakami M; Mizoguchi Y; Horibe Y; Komori K; Hori H; Kasahara M
APMIS; 1999 Nov; 107(11):1005-12. PubMed ID: 10598872
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
4. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
Moriki T; Takahashi T; Kataoka H; Hiroi M; Yamane T; Hara H
Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347
[TBL] [Abstract][Full Text] [Related]
5. Cell kinetic study of the endometrium by nonisotopic in situ hybridization for histone H3 messenger RNA and immunohistochemistry for Ki-67 and for estrogen and progesterone receptors.
Hayama M; Ota H; Toki T; Ishii K; Honda T; Momose M; Nakata R
Anat Rec; 2002 Apr; 266(4):234-40. PubMed ID: 11920386
[TBL] [Abstract][Full Text] [Related]
6. Use of in situ detection of histone mRNA in the assessment of epidermal proliferation: comparison with the Ki67 antigen and BrdU incorporation.
Smith MD; Healy E; Thompson V; Morley A; Rees JL
Br J Dermatol; 1995 Mar; 132(3):359-66. PubMed ID: 7718451
[TBL] [Abstract][Full Text] [Related]
7. Histone mRNA in-situ hybridization in astrocytomas: a comparison with PCNA, MIB-1 and mitoses in paraffin-embedded material.
Rautiainen E; Haapasalo H; Sallinen P; Rantala I; Helen P; Helin H
Histopathology; 1998 Jan; 32(1):43-50. PubMed ID: 9522215
[TBL] [Abstract][Full Text] [Related]
8. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
9. Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells.
Gown AM; Jiang JJ; Matles H; Skelly M; Goodpaster T; Cass L; Reshatof M; Spaulding D; Coltrera MD
J Histochem Cytochem; 1996 Mar; 44(3):221-6. PubMed ID: 8648081
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
Eldrige SR; Butterworth BE; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
12. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.
Zacchetti A; van Garderen E; Teske E; Nederbragt H; Dierendonck JH; Rutteman GR
APMIS; 2003 Mar; 111(3):430-8. PubMed ID: 12752223
[TBL] [Abstract][Full Text] [Related]
13. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
14. Histone H3 messenger RNA in situ hybridization for identifying proliferating cells in formalin-fixed rat gastric mucosa.
Maeyama H; Furuwatari C; Ota H; Akamatsu T; Nakayama J; Katsuyama T
Histochem J; 1997; 29(11-12):867-73. PubMed ID: 9466154
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue.
Birner P; Ritzi M; Musahl C; Knippers R; Gerdes J; Voigtländer T; Budka H; Hainfellner JA
Am J Pathol; 2001 Jun; 158(6):1991-6. PubMed ID: 11395376
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2'-deoxyuridine.
Connolly KM; Bogdanffy MS
J Histochem Cytochem; 1993 Jan; 41(1):1-6. PubMed ID: 7678022
[TBL] [Abstract][Full Text] [Related]
17. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
18. Determination of key aspects of precursor cell proliferation, cell cycle length and kinetics in the adult mouse subgranular zone.
Mandyam CD; Harburg GC; Eisch AJ
Neuroscience; 2007 Apr; 146(1):108-22. PubMed ID: 17307295
[TBL] [Abstract][Full Text] [Related]
19. Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area.
Wang LD; Zhou Q; Yang CS
J Cell Biochem Suppl; 1997; 28-29():159-65. PubMed ID: 9589362
[TBL] [Abstract][Full Text] [Related]
20. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Lee KS; Yang WI
Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
